Report Detail
Global (United States, European Union and China) Arthritis Drug Market Research Report 2019-2025
- RnM3681915 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
In 2019, the market size of Arthritis Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Arthritis Drug.
This report studies the global market size of Arthritis Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Arthritis Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
...
Market Segment by Product Type
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Market Segment by Application
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Arthritis Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Arthritis Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Arthritis Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Arthritis Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Synthetic DMARDs
- 1.3.3 Biological DMARDs
- 1.3.4 NSAIDs
- 1.3.5 Corticosteroids
- 1.3.6 Analgesics
- 1.4 Market Segment by Application
- 1.4.1 Global Arthritis Drug Market Share by Application (2019-2025)
- 1.4.2 Retail Pharmacies
- 1.4.3 Hospital Pharmacies
- 1.4.4 Drug Stores
- 1.4.5 E-Commerce
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Arthritis Drug Market Size
- 2.1.1 Global Arthritis Drug Revenue 2014-2025
- 2.1.2 Global Arthritis Drug Sales 2014-2025
- 2.2 Arthritis Drug Growth Rate by Regions
- 2.2.1 Global Arthritis Drug Sales by Regions 2014-2019
- 2.2.2 Global Arthritis Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Arthritis Drug Sales by Manufacturers
- 3.1.1 Arthritis Drug Sales by Manufacturers 2014-2019
- 3.1.2 Arthritis Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Arthritis Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Arthritis Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Arthritis Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Arthritis Drug Price by Manufacturers
- 3.4 Key Manufacturers Arthritis Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Arthritis Drug Market
- 3.6 Key Manufacturers Arthritis Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Synthetic DMARDs Sales and Revenue (2014-2019)
- 4.1.2 Biological DMARDs Sales and Revenue (2014-2019)
- 4.1.3 NSAIDs Sales and Revenue (2014-2019)
- 4.1.4 Corticosteroids Sales and Revenue (2014-2019)
- 4.1.5 Analgesics Sales and Revenue (2014-2019)
- 4.2 Global Arthritis Drug Sales Market Share by Type
- 4.3 Global Arthritis Drug Revenue Market Share by Type
- 4.4 Arthritis Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Arthritis Drug Sales by Application
6 United States
- 6.1 United States Arthritis Drug Breakdown Data by Company
- 6.2 United States Arthritis Drug Breakdown Data by Type
- 6.3 United States Arthritis Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Arthritis Drug Breakdown Data by Company
- 7.2 European Union Arthritis Drug Breakdown Data by Type
- 7.3 European Union Arthritis Drug Breakdown Data by Application
8 China
- 8.1 China Arthritis Drug Breakdown Data by Company
- 8.2 China Arthritis Drug Breakdown Data by Type
- 8.3 China Arthritis Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Arthritis Drug Breakdown Data by Company
- 9.2 Rest of World Arthritis Drug Breakdown Data by Type
- 9.3 Rest of World Arthritis Drug Breakdown Data by Application
- 9.4 Rest of World Arthritis Drug Breakdown Data by Countries
- 9.4.1 Rest of World Arthritis Drug Sales by Countries
- 9.4.2 Rest of World Arthritis Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Novartis
- 10.1.1 Novartis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Arthritis Drug
- 10.1.4 Arthritis Drug Product Introduction
- 10.1.5 Novartis Recent Development
- 10.2 Eli Lilly
- 10.2.1 Eli Lilly Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Arthritis Drug
- 10.2.4 Arthritis Drug Product Introduction
- 10.2.5 Eli Lilly Recent Development
- 10.3 Celltrion
- 10.3.1 Celltrion Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Arthritis Drug
- 10.3.4 Arthritis Drug Product Introduction
- 10.3.5 Celltrion Recent Development
- 10.4 F. Hoffmann-La Roche
- 10.4.1 F. Hoffmann-La Roche Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Arthritis Drug
- 10.4.4 Arthritis Drug Product Introduction
- 10.4.5 F. Hoffmann-La Roche Recent Development
- 10.5 Pfizer
- 10.5.1 Pfizer Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Arthritis Drug
- 10.5.4 Arthritis Drug Product Introduction
- 10.5.5 Pfizer Recent Development
- 10.6 Johnson & Johnson
- 10.6.1 Johnson & Johnson Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Arthritis Drug
- 10.6.4 Arthritis Drug Product Introduction
- 10.6.5 Johnson & Johnson Recent Development
- 10.7 GSK
- 10.7.1 GSK Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Arthritis Drug
- 10.7.4 Arthritis Drug Product Introduction
- 10.7.5 GSK Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Arthritis Drug Sales Channels
- 11.2.2 Arthritis Drug Distributors
- 11.3 Arthritis Drug Customers
12 Market Forecast
- 12.1 Global Arthritis Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Arthritis Drug Sales Forecast by Type
- 12.3 Global Arthritis Drug Sales Forecast by Application
- 12.4 Arthritis Drug Forecast by Regions
- 12.4.1 Global Arthritis Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Arthritis Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Arthritis Drug. Industry analysis & Market Report on Arthritis Drug is a syndicated market report, published as Global (United States, European Union and China) Arthritis Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Arthritis Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
